These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 20857056

  • 1. [Recent progress and novel perspectives on obesity pharmacotherapy].
    Faria AM, Mancini MC, Melo ME, Cercato C, Halpern A.
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):516-29. PubMed ID: 20857056
    [Abstract] [Full Text] [Related]

  • 2. New and emerging drug molecules against obesity.
    George M, Rajaram M, Shanmugam E.
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
    [Abstract] [Full Text] [Related]

  • 3. Overview of new antiobesity drugs.
    Hainer V.
    Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293
    [Abstract] [Full Text] [Related]

  • 4. Current Drug Targets in Obesity Pharmacotherapy - A Review.
    Bhat SP, Sharma A.
    Curr Drug Targets; 2017 Oct; 18(8):983-993. PubMed ID: 28245771
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM, Pritham Raj Y.
    Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug treatment of obesity: current status and future prospects.
    Kakkar AK, Dahiya N.
    Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Drug treatment of obesity--current situation and perspectives].
    Hainer V.
    Cas Lek Cesk; 2010 Mar; 149(11):513-9. PubMed ID: 21391349
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Weight Loss Pharmacotherapy: Current and Future Therapies.
    Jordan G, Young S, Alemán JO.
    Gastrointest Endosc Clin N Am; 2024 Oct; 34(4):591-608. PubMed ID: 39277293
    [Abstract] [Full Text] [Related]

  • 15. Past and present of antiobesity agents: focus on monoamine modulators.
    Khorassani FE, Misher A, Garris S.
    Am J Health Syst Pharm; 2015 May 01; 72(9):697-706. PubMed ID: 25873617
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phentermine and topiramate extended-release for the obesity: new kids on the block.
    Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I.
    Recent Pat Cardiovasc Drug Discov; 2013 Apr 01; 8(1):35-41. PubMed ID: 23565717
    [Abstract] [Full Text] [Related]

  • 18. Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy.
    Milano W, De Biasio V, Di Munzio W, Foggia G, Capasso A.
    Endocr Metab Immune Disord Drug Targets; 2020 Apr 01; 20(8):1232-1243. PubMed ID: 32410565
    [Abstract] [Full Text] [Related]

  • 19. The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.
    Gorelik E, Gorelik B, Masarwa R, Perlman A, Hirsh-Raccah B, Matok I.
    Int J Obes (Lond); 2020 May 01; 44(5):1021-1027. PubMed ID: 32152496
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.